GABAPENTIN 300 MG CAPSULE

GABAPENTIN
$0.0358per EA

Strength

300 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097094307

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

7/17/2024

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA090705

On Market Since

12/5/2017

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-15.8%

5Y

-25.4%

All

-17.9%